Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04050189Phase 2Completed
Phase 2, randomised, double-blind trial in perinatal complications (2 arms), sponsored by Centre de recherche du CHUS. Primary endpoint: In-utero transmission of probiotic. Started Apr 2022; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04050189.